|
US6982251B2
(en)
|
2000-12-20 |
2006-01-03 |
Schering Corporation |
Substituted 2-azetidinones useful as hypocholesterolemic agents
|
|
ATE331512T1
(de)
|
2001-01-26 |
2006-07-15 |
Schering Corp |
Verwendung azetidinone-substituierter verbindungen zur behandlung der sitosterolhämie
|
|
US7071181B2
(en)
|
2001-01-26 |
2006-07-04 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
|
|
MEP27808A
(en)
|
2001-01-26 |
2010-10-10 |
Schering Corp |
Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
|
|
CN1275949C
(zh)
|
2001-03-28 |
2006-09-20 |
先灵公司 |
2－吖丁啶酮中间体化合物的对映体选择性合成
|
|
US7056906B2
(en)
|
2001-09-21 |
2006-06-06 |
Schering Corporation |
Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
|
|
JP2005504091A
(ja)
|
2001-09-21 |
2005-02-10 |
シェーリング コーポレイション |
ステロール吸収阻害剤としてアゼチジノンを用いる黄色腫の処置
|
|
US7053080B2
(en)
|
2001-09-21 |
2006-05-30 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
|
|
AU2003237593A1
(en)
*
|
2002-06-05 |
2003-12-22 |
Natco Pharma Limited |
Process for the preparation of 4-(4-fluorobenzoyl) butyric acid
|
|
GB0215579D0
(en)
|
2002-07-05 |
2002-08-14 |
Astrazeneca Ab |
Chemical compounds
|
|
US7135556B2
(en)
|
2002-07-19 |
2006-11-14 |
Schering Corporation |
NPC1L1 (NPC3) and methods of use thereof
|
|
WO2004043457A1
(en)
|
2002-11-06 |
2004-05-27 |
Schering Corporation |
Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
|
|
MXPA05009501A
(es)
|
2003-03-07 |
2005-10-18 |
Schering Corp |
Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
|
|
CA2517571C
(en)
|
2003-03-07 |
2011-07-05 |
Schering Corporation |
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
|
|
EP1606287B1
(en)
|
2003-03-07 |
2013-10-02 |
Merck Sharp & Dohme Corp. |
Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
|
|
US7459442B2
(en)
|
2003-03-07 |
2008-12-02 |
Schering Corporation |
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
|
|
AR041089A1
(es)
|
2003-05-15 |
2005-05-04 |
Merck & Co Inc |
Procedimiento y composiciones farmaceutiicas para tratar aterosclerosis, dislipidemias y afecciones relacionadas
|
|
WO2005049592A1
(en)
|
2003-11-24 |
2005-06-02 |
Hetero Drugs Limited |
A novel process for ezetimibe intermediate
|
|
US7871998B2
(en)
|
2003-12-23 |
2011-01-18 |
Astrazeneca Ab |
Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity
|
|
MXPA06008124A
(es)
|
2004-01-16 |
2007-01-26 |
Merck & Co Inc |
Npc1l1 (npc3) y metodos para identificar ligandos del mismo.
|
|
US20060211752A1
(en)
|
2004-03-16 |
2006-09-21 |
Kohn Leonard D |
Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
|
|
WO2006050634A1
(en)
*
|
2004-11-15 |
2006-05-18 |
Xiamen Mchem Pharma (Group) Ltd. |
A preparation method of 1-(4-fluorophenyl)-(3r)-[3-(4-fluorophenyl)-(3s)-hydroxypropyl]-(4s)-(4-hydroxyphenyl)-2-azetidinone
|
|
EP1831162B1
(en)
*
|
2004-12-20 |
2012-10-31 |
Merck Sharp & Dohme Corp. |
Process for the synthesis of azetidinones
|
|
TW200726746A
(en)
*
|
2005-05-06 |
2007-07-16 |
Microbia Inc |
Processes for production of 4-biphenylylazetidin-2-ones
|
|
MX2007014172A
(es)
*
|
2005-05-11 |
2008-04-02 |
Microbia Inc |
Procedimiento para la produccion de 4-bifenililacetidina-2-onas fenolicos.
|
|
US20090099355A1
(en)
*
|
2005-05-25 |
2009-04-16 |
Microbia, Inc. |
Processes for Production of 4-(Biphenylyl)Azetidin-2-One Phosphonic Acids
|
|
SA06270191B1
(ar)
|
2005-06-22 |
2010-03-29 |
استرازينيكا ايه بي |
مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
|
|
WO2007017705A1
(en)
*
|
2005-08-09 |
2007-02-15 |
Glenmark Pharmaceuticals Limited |
Process for the preparation of azetidinones
|
|
WO2007048027A2
(en)
|
2005-10-21 |
2007-04-26 |
Novartis Ag |
Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent
|
|
HUP0501164A2
(en)
|
2005-12-20 |
2007-07-30 |
Richter Gedeon Nyrt |
New industrial process for the production of ezetimibe
|
|
CN101384532B
(zh)
*
|
2006-02-16 |
2013-01-02 |
寿制药株式会社 |
制造光学活性醇的方法
|
|
WO2007100807A2
(en)
|
2006-02-24 |
2007-09-07 |
Schering Corporation |
Npc1l1 orthologues
|
|
AR060623A1
(es)
|
2006-04-27 |
2008-07-02 |
Astrazeneca Ab |
Compuestos derivados de 2-azetidinona y un metodo de preparacion
|
|
CN100564357C
(zh)
*
|
2006-10-20 |
2009-12-02 |
浙江天宇药业有限公司 |
一种氮杂环丁酮衍生物及其合成方法
|
|
CZ305066B6
(cs)
*
|
2008-02-25 |
2015-04-22 |
Zentiva, K.S. |
Způsob výroby (3R,4S)-1-(4-fluorfenyl)-3-[(3S)-3-(4-fluorfenyl)-3-hydroxypropyl)]-4-(4-hydroxyfenyl)-2-azetidinonu
|
|
AR074752A1
(es)
*
|
2008-12-17 |
2011-02-09 |
Hanmi Pharm Ind Co Ltd |
Metodo para preparar ezetimiba e intermediarios usados en la misma
|
|
CA2757722C
(en)
|
2009-04-01 |
2018-05-22 |
Matrix Laboratories Ltd. |
Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
|
|
WO2010141494A2
(en)
*
|
2009-06-02 |
2010-12-09 |
Codexis, Inc. |
Synthesis of ezetimibe
|
|
CN101935309B
(zh)
*
|
2009-06-29 |
2013-11-13 |
上海特化医药科技有限公司 |
依泽替米贝的制备方法及其中间体
|
|
CN101845010B
(zh)
*
|
2010-02-10 |
2012-07-25 |
浙江大学 |
一种制备伊替米贝的方法
|
|
ES2372460B1
(es)
|
2010-07-09 |
2012-11-16 |
Moehs Ibérica S.L. |
Nuevo método para la preparación de ezetimiba.
|
|
WO2012076030A1
(en)
*
|
2010-12-10 |
2012-06-14 |
Pharmathen S.A. |
Process for the preparation of intermediate compounds useful in the preparation of ezetimibe
|
|
CN103570574B
(zh)
*
|
2012-07-20 |
2016-04-13 |
中国科学院上海有机化学研究所 |
一种依泽替米贝的合成方法及该方法中所用的中间体
|
|
CN103102297A
(zh)
*
|
2012-09-28 |
2013-05-15 |
北京赛林泰医药技术有限公司 |
一种新的依折麦布的合成方法
|
|
CN103864708A
(zh)
*
|
2012-12-12 |
2014-06-18 |
天津市医药集团技术发展有限公司 |
一种依折麦布中间体的制备方法
|
|
WO2015039675A1
(en)
|
2013-09-23 |
2015-03-26 |
Pharmathen S.A. |
Novel process for the preparation of ezetimibe intermediates
|
|
CN103739537B
(zh)
*
|
2013-12-24 |
2015-05-20 |
连云港恒运医药科技有限公司 |
依折麦布的新合成方法
|
|
CN103819382A
(zh)
*
|
2014-01-01 |
2014-05-28 |
北京万全德众医药生物技术有限公司 |
一种依折麦布杂质的制备方法
|
|
CN103965089B
(zh)
*
|
2014-04-18 |
2016-06-29 |
上海方楠生物科技有限公司 |
一种立体选择性的合成降血脂药物依折麦布的方法
|
|
CN104230978B
(zh)
*
|
2014-09-22 |
2016-09-28 |
上海现代制药股份有限公司 |
依折麦布的制备中间体及其制备方法
|
|
CN104447474A
(zh)
*
|
2014-11-11 |
2015-03-25 |
武汉武药科技有限公司 |
一种依折麦布异构体的合成方法
|
|
CN104402790B
(zh)
*
|
2014-12-28 |
2016-09-28 |
严白双 |
一种制备依折麦布的改进工艺
|
|
KR102370582B1
(ko)
|
2015-03-13 |
2022-03-04 |
에스페리온 테라피유틱스 인코포레이티드 |
Ｅｔｃ1002 및 에제티미브를 포함하는 고정 용량 조합 및 제형 및 심혈관 질환의 치료 또는 이의 위험의 감소 방법
|
|
MA41793A
(fr)
|
2015-03-16 |
2018-01-23 |
Esperion Therapeutics Inc |
Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire
|
|
CN104892537B
(zh)
*
|
2015-05-15 |
2018-07-17 |
江西施美药业股份有限公司 |
依折麦布中间体以及依折麦布的合成方法
|
|
CN104829511A
(zh)
*
|
2015-05-18 |
2015-08-12 |
广州南新制药有限公司 |
一种依折麦布的合成工艺
|
|
CN105237492A
(zh)
*
|
2015-10-29 |
2016-01-13 |
无锡福祈制药有限公司 |
一种依折麦布中间体的合成方法
|
|
CN105524010B
(zh)
*
|
2015-12-16 |
2018-10-26 |
江苏恒盛药业有限公司 |
一种依泽麦布中间体及其制备方法
|
|
CN105566243B
(zh)
*
|
2016-01-15 |
2017-10-31 |
齐鲁天和惠世制药有限公司 |
从依折麦布生产废液中回收(s)‑(+)‑4‑苯基‑2‑噁唑烷酮的方法
|
|
CN107098841A
(zh)
*
|
2016-02-19 |
2017-08-29 |
常州方楠医药技术有限公司 |
一种依折麦布的制备方法及该方法中所用的中间体
|
|
JP6711709B2
(ja)
*
|
2016-05-10 |
2020-06-17 |
株式会社トクヤマ |
エゼチミブの製造方法
|
|
CN106967106B
(zh)
*
|
2017-04-24 |
2018-08-10 |
上海华源医药科技发展有限公司 |
一种依折麦布中间体的生产方法
|
|
JP6802121B2
(ja)
|
2017-08-04 |
2020-12-16 |
株式会社シマノ |
自転車用コンポーネント
|
|
CN110818606B
(zh)
*
|
2018-08-08 |
2021-06-29 |
上海博志研新药物技术有限公司 |
依折麦布及其中间体的制备方法
|
|
CN112441959A
(zh)
*
|
2020-12-07 |
2021-03-05 |
石家庄市华新药业有限责任公司 |
一种依折麦布原料药合成工艺
|
|
CN115850144A
(zh)
*
|
2022-12-30 |
2023-03-28 |
湖南方盛绿色合成制药有限公司 |
依折麦布的制备工艺
|
|
CN116283948A
(zh)
*
|
2023-02-24 |
2023-06-23 |
江苏阿尔法药业股份有限公司 |
一种依折麦布中间体的合成方法
|
|
CN117843543A
(zh)
*
|
2024-01-02 |
2024-04-09 |
南京工业大学 |
一种α,α-二氟丁内酰胺的制备方法
|